Award Data

C53-20b-271305The prospect of nuclear power produced with advanced molten salt-cooled reactor (MSR) designs has garnered the attention of the Department of Energy in conjunction with the private sector. The salts are used to transfer heat from the reacting fuel. All designs describe a chemically stable salt with a melting point near 500°C, heated by the nuclear reaction to a temperature near 700 ...

The broader/commercial impact of this Small Business Innovation Research (SBIR) Phase II project is to provide an ecofriendly, efficient, and cost affordable adjuvant product to solve the pressing problem of herbicide drift. For years, farmers growing organic, non-genetically modified (non-GM) and specialty crops have incurred financial losses in the hundreds of millions of dollars due to drift of ...

The broader impacts of this Small Business Innovation Research (SBIR) Phase II project include an artificial intelligence technology designed to detect, identify, and determine levels of insect infestations in fields, providing a comprehensive decision support system in real-time.More efficient and precise insect monitoring would result in reduced chemical insecticide use by increasing the specifi ...

The prospect of nuclear power produced with advanced molten salt-cooled reactor (MSR) designs has garnered the attention of the Department of Energy in conjunction with the private sector. Modern designs describe a chemically stable salt such as FLiNaK with a melting point below 500°C, heated by the nuclear reaction to a temperature near 700°C. Continuous operation of MSR heat-exchange loops req ...

PROJECT SUMMARY In this Direct-to-Phase II SBIR, BioStrategies LC proposes to advance the development of a novel AAV- based gene therapy for mucopolysaccharidosis type IIIA (MPS IIIA, also known as Sanfilippo A syndrome). In contrast to other gene therapies in development for MPS IIIA, BioStrategies’ approach is designed to achieve a systemic therapeutic effect, including delivery of a functiona ...

Advanced Development of GeminiTM-DHAP Project Summary:The Specific Aim of this Direct to Phase II project is to develop a discrete, low-profile, dual hormone artificial pancreas device, the GeminiTM-DHAP, using SFC Fluidics' enabling microfluidic technologies to deliver both insulin and glucagon as recommended by a dual-hormone algorithm in response to continuous glucose monitor readings. The Gemi ...

Project Summary The goal of this Direct to Phase II program is to develop and test the efficacy of a Precision Medicine Clinical Trials Enrollment Platform for kidney diseases. Approximately half of randomized controlled trials do not meet their recruiting target. Enrolling trials targeting rare kidney diseases is particularly challenging with many conditions subject to stratification and sub-typi ...

The objective of this program is to improve the manufacturing processes and production yields of high- performance thin film coatings used in infrared imaging systems. The improvement effort will concentrate on reducing coating absorption and scatter caused by internal and surface defects. The required improvements specifically apply to IR filter coatings positioned in proximity to focal plane arr ...

In this project, Arktonics will develop a revolutionary infrared sensor technology platform offering monolithic integration of Complementary Metal–Oxide–Semiconductor (CMOS) circuits with a high-performance detector array made from an emerging group-IV al

Redacted.